CI Investments Inc
JAZZ icon

CI Investments Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

CI Investments Inc’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
+958
New +$210K ﹤0.01% 730
2025
Q4 		– Sell
-787
Closed -$104K – 955
2025
Q3 		$104K Sell
787
-308
-28% -$36.9K ﹤0.01% 864
2025
Q2 		$116K Sell
1,095
-464
-30% -$50.4K ﹤0.01% 872
2025
Q1 		$194K Sell
1,559
-640
-29% -$83.5K ﹤0.01% 732
2024
Q4 		$271K Buy
2,199
+84
+4% +$9.9K ﹤0.01% 649
2024
Q3 		$236K Sell
2,115
-12
-0.6% -$1.31K ﹤0.01% 617
2024
Q2 		$227K Sell
2,127
-1,121
-35% -$123K ﹤0.01% 608
2024
Q1 		$391K Buy
3,248
+869
+37% +$106K ﹤0.01% 524
2023
Q4 		$293K Sell
2,379
-163
-6% -$20.3K ﹤0.01% 539
2023
Q3 		$329K Buy
2,542
+210
+9% +$28K ﹤0.01% 511
2023
Q2 		$289K Buy
2,332
+676
+41% +$91K ﹤0.01% 574
2023
Q1 		$242K Buy
1,656
+448
+37% +$66.3K ﹤0.01% 557
2022
Q4 		$192K Buy
1,208
+155
+15% +$22.7K ﹤0.01% 612
2022
Q3 		$140K Buy
1,053
+2
+0.2% +$304 ﹤0.01% 651
2022
Q2 		$164K Sell
1,051
-202
-16% -$31.1K ﹤0.01% 643
2022
Q1 		$195K Sell
1,253
-123
-9% -$17.8K ﹤0.01% 707
2021
Q4 		$175K Buy
1,376
+60
+5% +$7.88K ﹤0.01% 782
2021
Q3 		$171K Buy
1,316
+345
+36% +$52.1K ﹤0.01% 755
2021
Q2 		$172K Sell
971
-291
-23% -$50.4K ﹤0.01% 771
2021
Q1 		$207K Buy
1,262
+368
+41% +$60.6K ﹤0.01% 658
2020
Q4 		$148K Buy
894
+325
+57% +$48.4K ﹤0.01% 691
2020
Q3 		$81K Buy
569
+135
+31% +$16.7K ﹤0.01% 689
2020
Q2 		$48K Buy
434
+68
+19% +$7.52K ﹤0.01% 604
2020
Q1 		$37K Buy
366
+120
+49% +$15.5K ﹤0.01% 561
2019
Q4 		$37K Buy
246
+220
+846% +$29.9K ﹤0.01% 594
2019
Q3 		$3K Buy
+26
New +$3.48K ﹤0.01% 585

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

CI Investments Inc's JAZZ Position: Q2 2026 in Review

CI Investments Inc opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 958 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #730 among its holdings. This is a return to the name: CI Investments Inc previously reported a position in JAZZ as recently as Q3 2025.

CI Investments Inc first reported a position in JAZZ in Q3 2019 and has held it in 26 quarters since. The position peaked at $391K in Q1 2024. 643 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • CI Investments Inc held 958 shares of Jazz Pharmaceuticals worth $231K as of Q2 2026.
  • Jazz Pharmaceuticals was a new CI Investments Inc position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of CI Investments Inc's portfolio in Q2 2026, its #730 holding.
  • CI Investments Inc first reported a position in Jazz Pharmaceuticals in Q3 2019 and has held it in 26 quarters since.
  • CI Investments Inc's Jazz Pharmaceuticals position peaked at $391K in Q1 2024.
  • 643 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.